Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Predictors of discontinuation of Biologic DMARD therapy due to remission in patients with Rheumatoid Arthritis in a National Registry (BIOBADASER)

11/01/2017

Jose A. Gómez-Puerta, M Victoria Hernandez, Fernando Alonso, Kazuki Yoshida, Raimon Sanmartí, Dan H. Solomon, Juan J. Gómez-Reino

Jose A. Gómez-Puerta, M Victoria Hernandez, Fernando Alonso, Kazuki Yoshida, Raimon Sanmartí, Dan H. Solomon, Juan J. Gómez-Reino on behalf of BIOBADASER 2.0 study group.  Predictors of discontinuation of Biologic DMARD therapy due to remission in patients with Rheumatoid Arthritis in a National Registry (BIOBADASER). Congreso ACR 2014. Póster.